Medico Remedies Ltd.

NSE: MEDICO BSE: 540937 SECTOR: Pharmaceuticals & Drugs  7441   18   2

74.10
-3.05 (-3.95%)
NSE: 29 Mar 4:00 PM

Price Summary

Today's High

₹ 78.8

Today's Low

₹ 73.6

52 Week High

₹ 86.95

52 Week Low

₹ 16.52

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

614.91 Cr.

Enterprise Value

623.18 Cr.

No. of Shares

8.3 Cr.

P/E

125.74

P/B

14.63

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  5.07

CASH

2.34 Cr.

DEBT

10.61 Cr.

Promoter Holding

73.34 %

EPS (TTM)

₹  0.59

Sales Growth

-1.12%

ROE

14.02 %

ROCE

15%

Profit Growth

88.8 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-1.12%
3 Year7.4%
5 Year17.33%

Profit Growth

1 Year88.8%
3 Year46.04%
5 Year24.6%

ROE%

1 Year14.02%
3 Year9.31%
5 Year7.87%

ROCE %

1 Year15%
3 Year10.93%
5 Year9.92%

Debt/Equity

0.2843

Price to Cash Flow

359.6

Interest Cover Ratio

11.7377049180328

CFO/PAT (5 Yr. Avg.)

0.118203029238459

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2022 73.34 0
Sep 2022 73.34 0
Jun 2022 73.34 0
Mar 2022 73.34 0
Dec 2021 73.34 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 46.0358840081695% for the Past 3 years.
  • Company has a healthy Interest coverage ratio of 11.7377049180328.
  • The company has an efficient Cash Conversion Cycle of 2.48419973301563 days.
  • The company has a high promoter holding of 73.34%.

 Limitations

  • The company has shown a poor revenue growth of 7.40028904133325% for the Past 3 years.
  • The company is trading at a high EV/EBITDA of 66.9948.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2022 Sep 2022 Dec 2022
Net Sales 33.14 40.46 38.85
Total Expenditure 33.32 37.32 35.46
Operating Profit -0.18 3.15 3.39
Other Income 1.6 1.55 0.86
Interest 0.17 0.17 0.2
Depreciation 0.59 0.66 0.74
Exceptional Items 0 0 0
Profit Before Tax 0.65 3.86 3.32
Tax 0.29 0.99 1.07
Profit After Tax 0.36 2.87 2.25
Adjusted EPS (Rs) 0.04 0.35 0.27

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 61.02 97.69 88.64 122.39 121.02
Total Expenditure 57.54 94.93 85.8 117.15 113.81
Operating Profit 3.48 2.76 2.84 5.24 7.21
Other Income 0.91 1.9 2.1 1.03 2.03
Interest 1.52 0.98 1.06 0.92 0.61
Depreciation 1 1.51 1.66 1.65 2.08
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.87 2.18 2.22 3.7 6.55
Tax 0.65 0.6 0.58 1.11 1.66
Net Profit 1.22 1.57 1.63 2.59 4.89
Adjusted EPS (Rs.) 0.15 0.19 0.2 0.31 0.59

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 4.15 4.15 4.15 4.15 16.6
Total Reserves 22.52 24.09 25.72 28.31 20.72
Borrowings 2.19 2.37 4.71 4.95 0.9
Other N/C liabilities 0.36 0.25 0.22 0.26 0.08
Current liabilities 30.17 45.45 40.48 37.95 37.89
Total Liabilities 59.39 76.31 75.27 75.62 76.19
Assets
Net Block 6.63 12.27 12.55 15.31 16.09
Capital WIP 4.37 0.9 2.28 0 0
Intangible WIP 0 0 0 0 0
Investments 0.24 0.15 0.15 0.11 0
Loans & Advances 2.46 3.77 3.59 1.72 1.54
Other N/C Assets 0 0.05 0.06 0 0
Current Assets 45.69 59.18 56.64 58.48 58.56
Total Assets 59.39 76.31 75.27 75.62 76.19
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations 1.87 2.18 2.22 3.68 6.55
Adjustment 2.15 1.86 2.14 2.57 2.69
Changes in Assets & Liabilities 1.64 1.49 -2.81 -16.63 -5.74
Tax Paid -0.55 -0.55 -0.54 -0.93 -1.79
Operating Cash Flow 5.1 4.94 0.97 -11.31 1.71
Investing Cash Flow -4.98 -4.43 -3.08 -16.96 -2.86
Financing Cash Flow -0.62 -0.55 2.6 18.28 7.4
Net Cash Flow -0.5 -0.04 0.48 -9.99 6.25

Corporate Actions

Investors Details

PARTICULARS Dec 2021% Mar 2022% Jun 2022% Sep 2022% Dec 2022%
Promoters 73.34 73.34 73.34 73.34 73.34
haresh k mehta 16.56 16.56 16.56 16.56 -
haresh kapurlal me... - - - - 16.56
haresh k mehta huf - 11.90 11.90 11.90 11.90
haresh k mehta huf... 11.90 - - - -
rita haresh mehta - 10.40 10.40 10.40 -
rita haresh mehta . 10.40 - - - -
rita h mehta - - - - 10.40
rishit hareshbhai ... 9.49 9.49 9.49 9.49 9.49
harshit haresh meh... 9.11 9.11 9.11 9.11 9.11
shweta harshit meh... - 8.75 8.75 8.75 8.75
shweta harshit meh... 8.75 - - - -
priyal rishit mehta - 6.27 6.27 6.27 6.27
priyal rishit meht... 6.27 - - - -
harshit h mehta huf - 0.87 0.87 0.87 0.87
harshit h mehta hu... 0.87 - - - -
PARTICULARS Dec 2021% Mar 2022% Jun 2022% Sep 2022% Dec 2022%
Investors 26.66 26.66 26.66 26.66 26.66
nopea capital serv... 3.37 3.42 - - -
emrald commercial ... 4.54 4.54 4.54 4.54 2.50
s k growth fund pv... 4.02 4.02 4.02 3.13 2.72
nopea capital serv... - - 3.42 2.21 2.21
venkateshwara indu... 3.18 3.19 3.20 2.40 2.40
escorp asset manag... 3.07 3.07 3.07 3.07 1.78
vijaygopal parasra... - - 2.08 2.08 2.08
sanjay narendra ba... - - 1.50 1.50 1.50

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Medico Remedies Stock Price Analysis and Quick Research Report. Is Medico Remedies an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Medico Remedies and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 1.71 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Medico Remedies has a Debt to Equity ratio of 0.2843 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Medico Remedies , the EPS growth was 88.8091270349955 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Medico Remedies has OPM of 5.95769294331515 % which is a bad sign for profitability.
     
  • ROE: Medico Remedies have a average ROE of 14.0154772141015 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Medico Remedies

X